The recently revised label on propofol 200 mg/20 mL vials by Sagent Pharmaceuticals is likely to cause problems during barcode scanning now that the barcode is printed horizontally around a curved surface (Figure 1).
Previously, the barcode was printed vertically and was easy to scan. We have received reports of significant scanning issues, and one organization that reported this is now purchasing the drug from a different source. The October 19, 2017, issue of the ISMP Medication Safety Alert! included an article about unreadable barcodes with examples of other products with similar issues. ISMP has notified both the US Food and Drug Administration (FDA) and Sagent. We are investigating whether other products and strengths have been similarly revised. Other pharmaceutical companies need to take notice, as scanners often can’t read linear barcodes printed on a curved surface.
B. Braun recently announced a new presentation of potassium chloride for injection concentrate (2 mEq/mL) in a 250 mL EXCEL container plastic bag with blue and red labeling, and a blocked medication port. The 250 mL product is a pharmacy bulk package and should only be used in a pharmacy admixture
On December 22, 2021, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for PAXLOVID, consisting of oral tablets of nirmatrelvir that are co-packaged with oral tablets of ritonavir (an FDA-approved antiretroviral agent). Indications Emergency use of Paxlovid is
Ever since the US Food and Drug Administration (FDA) authorized the emergency use of a specific formulation (10 mcg/0.2 mL) of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine for children ages 5 through 11 years, reports of mix-ups with the Pfizer-BioNTech COVID-19 vaccine